These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 3020728)

  • 1. [Cyclic AMP level in T- and B lymphocytes in patients with rheumatoid arthritis and systemic lupus erythematosus].
    Bandzhiulene SIu; Matulis AA
    Ter Arkh; 1986; 58(7):46-9. PubMed ID: 3020728
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Up-regulation of cellular FLICE-inhibitory protein in peripheral blood B lymphocytes in patients with systemic lupus erythematosus is associated with clinical characteristics.
    Tao J; Dong J; Li Y; Liu YQ; Yang J; Wu Y; Li L; Shen GX; Tan ZJ; Tu YT
    J Eur Acad Dermatol Venereol; 2009 Apr; 23(4):433-7. PubMed ID: 19335730
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Direct transfer of p65 into T lymphocytes from systemic lupus erythematosus patients leads to increased levels of interleukin-2 promoter activity.
    Herndon TM; Juang YT; Solomou EE; Rothwell SW; Gourley MF; Tsokos GC
    Clin Immunol; 2002 May; 103(2):145-53. PubMed ID: 12027419
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The quantitative analysis of peripheral blood FOXP3-expressing T cells in systemic lupus erythematosus and rheumatoid arthritis patients.
    Lin SC; Chen KH; Lin CH; Kuo CC; Ling QD; Chan CH
    Eur J Clin Invest; 2007 Dec; 37(12):987-96. PubMed ID: 18036033
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Peripheral blood lymphocytes in SLE--hyperexpression of CD154 on T and B lymphocytes and increased number of double negative T cells.
    Devi BS; Van Noordin S; Krausz T; Davies KA
    J Autoimmun; 1998 Oct; 11(5):471-5. PubMed ID: 9802931
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Abnormal NF-kappa B activity in T lymphocytes from patients with systemic lupus erythematosus is associated with decreased p65-RelA protein expression.
    Wong HK; Kammer GM; Dennis G; Tsokos GC
    J Immunol; 1999 Aug; 163(3):1682-9. PubMed ID: 10415075
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Patients with rheumatoid arthritis and systemic lupus erythematosus have increased renal excretion of mitogenic estrogens in relation to endogenous antiestrogens.
    Weidler C; Härle P; Schedel J; Schmidt M; Schölmerich J; Straub RH
    J Rheumatol; 2004 Mar; 31(3):489-94. PubMed ID: 14994392
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Binding of nuclear proteins to the negative regulatory element of the IL-2 gene in lymphocytes from rheumatic patients.
    Flescher E; Vela-Roch N; Talal N; Dang H
    Cytokine; 1999 Mar; 11(3):187-91. PubMed ID: 10209065
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cortisol catabolism by lymphocytes of patients with systemic lupus erythematosus and rheumatoid arthritis.
    Klein A; Buskila D; Gladman D; Bruser B; Malkin A
    J Rheumatol; 1990 Jan; 17(1):30-3. PubMed ID: 2313669
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Deficient type I protein kinase A isozyme activity in systemic lupus erythematosus T lymphocytes: II. Abnormal isozyme kinetics.
    Kammer GM; Khan IU; Kammer JA; Olorenshaw I; Mathis D
    J Immunol; 1996 Sep; 157(6):2690-8. PubMed ID: 8805675
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum cortisol reduction and abnormal prolactin and CD4+/CD8+ T-cell response as a result of controlled exercise in patients with rheumatoid arthritis and systemic lupus erythematosus despite unaltered muscle energetics.
    Pool AJ; Whipp BJ; Skasick AJ; Alavi A; Bland JM; Axford JS
    Rheumatology (Oxford); 2004 Jan; 43(1):43-8. PubMed ID: 12867581
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhanced propensity of T lymphocytes in patients with systemic lupus erythematosus to apoptosis in the presence of tumour necrosis factor alpha.
    Habib HM; Taher TE; Isenberg DA; Mageed RA
    Scand J Rheumatol; 2009; 38(2):112-20. PubMed ID: 19110660
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The use of T cell subtyping to distinguish rheumatoid arthritis from systemic lupus erythematosus.
    Traycoff RB; Rogers WW; Gregory SA
    J Rheumatol; 1981; 8(3):494-7. PubMed ID: 6974781
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The detecting and clinical value of anti-cyclic citrullinated peptide antibodies in patients with systemic lupus erythematosus.
    Qing YF; Zhang QB; Zhou JG; Yuan GH; Wei J; Xing Y; Liu JP; Jiang L; Chen JP
    Lupus; 2009 Jul; 18(8):713-7. PubMed ID: 19502267
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Abnormal telomerase activity and telomere length in T and B cells from patients with systemic lupus erythematosus.
    Kurosaka D; Yasuda J; Yoshida K; Yoneda A; Yasuda C; Kingetsu I; Toyokawa Y; Yokoyama T; Saito S; Yamada A
    J Rheumatol; 2006 Jun; 33(6):1102-7. PubMed ID: 16755657
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analyses of lymphocytes from patients with rheumatoid arthritis and systemic lupus erythematosus. Occurrence of interfering cold-reactive antilymphocyte antibodies.
    Winchester RJ; Winfield JB; Siegal F; Wernet P; Bentwich Z; Kunkel HG
    J Clin Invest; 1974 Nov; 54(5):1082-92. PubMed ID: 4138924
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Costimulatory molecule CD154 in systemic lupus erythematosus and rheumatoid arthritis. Therapeutic perspectives.
    Dejica DI; Manea EM
    Roum Arch Microbiol Immunol; 2006; 65(1-2):66-74. PubMed ID: 17877113
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression and function of inducible costimulator on peripheral blood T cells in patients with systemic lupus erythematosus.
    Yang JH; Zhang J; Cai Q; Zhao DB; Wang J; Guo PE; Liu L; Han XH; Shen Q
    Rheumatology (Oxford); 2005 Oct; 44(10):1245-54. PubMed ID: 15987711
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Abnormally elevated frequency of Epstein-Barr virus-infected B cells in the blood of patients with rheumatoid arthritis.
    Tosato G; Steinberg AD; Yarchoan R; Heilman CA; Pike SE; De Seau V; Blaese RM
    J Clin Invest; 1984 Jun; 73(6):1789-95. PubMed ID: 6327772
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Patterns of in vitro aspirin hydrolysis rates in rheumatoid arthritis and systemic lupus erythematosus.
    Costello PB; Green FA
    J Rheumatol; 1986 Oct; 13(5):882-6. PubMed ID: 3820197
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.